Dr Paul Ross, Consultant Oncologist
Dr Paul Ross
Consultant Oncologist
Dr Paul Ross PhD MRCP
Consultant Oncologist
Dr Paul Ross
Consultant Oncologist PhD MRCP
Areas of expertise
- Gastrointestinal Cancers
- Liver Cancer
- Medical Oncology
- Neuroendocrine Tumours (NETs)
- Pancreatic Cancer
Make an appointment
Address
-
LOC at Chelsea
102 Sydney Street, Chelsea, London, SW3 6NJ
-
London Bridge Hospital
27 Tooley Street, London, SE1 2PR
-
Private Care at Guy's at London Bridge Hospital
Great Maze Pond, London, SE1 9RT
About Dr Paul Ross
GMC number: 3495412
Year qualified: 1990
Place of primary qualification: University of London
Dr Paul Ross is a leading consultant oncologist with HCA Healthcare at London Bridge Hospital, The Lister Hospital, and The Harley Street Clinic. He also holds an NHS post at Guy's and St. Thomas' Hospital in South London. His subspecialty includes treating cancers of the gastrointestinal tract, liver, gall bladder, and pancreas. Additionally, he has vast experience in managing neuroendocrine tumours.
Dr Ross offers a holistic approach to cancer treatment, integrating biological therapies where appropriate. He is heavily involved in research and serves as the chief investigator on numerous studies, including those focused on locoregional therapy. His commitment to optimising his patients' wellbeing and outcomes is evident in his comprehensive care strategies.
Dr Ross's areas of expertise include chemotherapy, biological therapy, and locoregional therapy. He treats a wide range of conditions, including gastrointestinal cancer, neuroendocrine tumours, hepatobiliary cancer, liver cancer, upper gastrointestinal cancer, lower gastrointestinal cancer, and pancreatic cancer.
Dr Ross continues to contribute significantly to the field of oncology through both his clinical practice and research initiatives. His dedication to advancing cancer treatment and improving patient outcomes makes him a highly respected figure in his field.
Areas of expertise
- Biological Therapy
- Chemotherapy
- Gastrointestinal Cancers
- Liver Cancer
- Medical Oncology
- Neuroendocrine Tumours (NETs)
- Pancreatic Cancer